Showing results (351-360 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|May 8, 2001
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humansR Büscher, H Belger, K J Eilmes, et al.Pharmacogenetics|May 8, 2001
MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicityM M Ameyaw, F Regateiro, T Li, et al.Pharmacogenetics|May 8, 2001
Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in JapaneseK Kumagai, K Hiyama, S Ishioka, et al.Pharmacogenetics|February 4, 2003
Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipientsBalram Chowbay, Sivathasan Cumaraswamy, Yin Bun Cheung, et al.Pharmacogenetics|February 4, 2003
Human genetic variations in the 5HT2A receptor: a single nucleotide polymorphism identified with altered response to clozapineLayne Harvey, Ronald E Reid, Caixia Ma, et al.Pharmacogenetics|April 2, 2003
Pharmacogenetics of hepatocellular transportersChristiane Pauli-Magnus, Peter J MeierPharmacogenetics|April 2, 2003
Adherence to and dosing of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-genotypesAnke-Hilse Maitland-van der Zee, Bruno H Ch Stricker, Olaf H Klungel, et al.Pharmacogenetics|March 6, 2003
Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6Ai-Ming Yu, Jeffrey R Idle, Linda G Byrd, et al.Pharmacogenetics|June 5, 2003
CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependenceLisa A Howard, Jasjit S Ahluwalia, Shih-Ku Lin, et al.Pharmacogenetics|June 5, 2003
CYP2E1 and NQO1 genotypes, smoking and bladder cancerJi-Yeob Choi, Kyoung-Mu Lee, Soo-Hun Cho, et al.Pageof 83